{"id":"dose-given-at-day-0","phase":"phase_1","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"active","trials":["NCT01302990"],"aliases":[],"patents":[],"pricing":[],"timeline":[],"aiSummary":"The study \"Doxy-PEP: Dose-Ranging Study of Persons Receiving Doxycycline\" is investigating the use of doxycycline for post-exposure prophylaxis in various conditions, including sexually transmitted diseases and ricin poisoning. The study is being conducted by Emory University and is also known as NCT05853120.","brandName":"Dose given at Day 0","companyId":"medicago","mechanism":{"target":"","novelty":"","modality":"Biologic","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"_claudeStub":{"ts":1779123426,"model":"claude-sonnet-4-5-20250929"},"companyName":"Medicago","competitors":[],"description":"Dose given at Day 0 is an investigational therapeutic developed by Medicago currently in Phase 1 clinical trials. Limited public information is available regarding its molecular target, mechanism of action, or specific therapeutic indication at this early stage of development.","genericName":"Dose given at Day 0","indications":{"approved":[{"status":"investigational","condition":null,"patientPopulation":null}],"offLabel":[],"pipeline":[]},"labelChanges":[],"trialDetails":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"rwe":[],"genericFilers":[],"relatedDrugs":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"modality":"Biologic","enrichmentLevel":2,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}